Professional Documents
Culture Documents
Chapter 1-4 Answers
Chapter 1-4 Answers
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE 1
GENERAL
REQUIREMENTS FOR
ISSUANCE OF LTO
BY BFAD
TERMS TO DEFINE
PHARMACY
DRUGS
POISON
CODE
BIOLOGIC PRODUCTS
WHOLESALER
DEVICE
CIPHER
SECRET KEYS
PHARMACEUTICAL MEDICINES
BIO-REF
REQUIREMENTS FOR
DRUGSTORE/RETAIL OUTLET FOR
NON-RX DRUGS
Registration cert.
PRC-ID
valid PTR
ID picture
cert. of attendance to BFAD seminar
Single proprietorship
Corporation
Contract of lease
Picture of drugstore with signboard
Requirement
Petition Form
Requirement
Joint Affidavit of
Undertaking
Paracetamol
Biogesic
Tempra
Tylenol
Winadol
Acetadol
Rexidol
License To Operate
Pharmacist
Registration of
certificate
Pharmacist
Business Registration
Pharmacist
PRC ID
Pharmacist
Certificate of attendance
REFERENCE BOOKS
PNDF
RA 3720
RA 6675
RA 5921
RA 8203
USP/NF
RPS
Goodman and Gilman Pharmacological Basis
of Therapeutics
Reference Book
Philippine National Drug
Formulary
Reference Book
Remington
Pharmaceutical
Sciences
Reference Book
UNITED STATE
PHARMACOPEIA
RECORD BOOKS
Prescription Book
Dangerous Drug Book
Poison Book
Prescription Book
Prescription Book
POISON/CHEMICAL BOOK
OPIUM BOOK
PRESCRIPTION BOOK
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE NO. 2
THE CONTROL OF
PHARMACY
PROFESSION
Terms To Define
STATUTORY LAW
COMMON LAW
ETHICS
REGULATORY LAW
JURISPRUDENCE
COMPREHENSIVE DANGEROUS
DRUG ACT R.A. 9165
PRINCIPLES OF PROFESSIONAL
CONDUCT
Service to others
Integrity and Objectivity
Professional competence
CODE OF ETHICS
IMPORTANCE
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE 3
THE COMMUNITY
PHARMACY
PROFILE
TRADITIONAL MARKET
DRUGSTORE
PERSONNEL
STORE HOURS
NON-TRADITIONAL MARKET
Customer services
Equipment /facilities
COMPARISON OF COMMUNITY
PHARMACY IN 1990S AND 2000S
Location
signboards
Staffing pattern
Pharmacist
Communication
Store facilities
Capitalization
Transportation
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
Exercise 4
THERAPEUTIC
CATEGORIES OF
DRUGS BY PNDF
PNDF
DANGEROUS DRUGS
BFAD
THERAPEUTIC COMMITTEES
CORE/ MAIN LIST
COMPLEMENTARY LIST
to other therapies
The drug is a fixed dose combination which
does not satisfy the requirements of AO 96 s.
1990
Core List
Acetylcysteine
Azathioprine
Clofazimine
Cobra antivenin
Dantrolene
Diazepam
Diethylcarbamazepine
Diphtheria-tetanus toxoids
Dimercaprol
endrophonium
Ergocalciferol
Fluorecein
Folic acid
Hydrochlorthiazide
Hydrocortisone
Hydroxycobalamine
Indomethacin inj
Iodine
INH + ethambutol
INH + rifampicin
Praziquantrel
Retinol
Na Ca edetate
NaI 131I
Na nitrite
Na nitroprusside
Na thiosulfate
Succimer
Thiamine
Tuberculin purified protein
derivative
Complementary List
Aciclovir eye ointment
Alpha-tocopherol
Al acetate
Cromolyn
Buserelin
Busulfan
Chloral hydrate
Chlormethine
Dithranol
estramustine
Hydroxycobalamin
Indomethacin
Iodamide
Iron dextran
Povidone iodide
Pralidoxime Cl
Pyrimethamine
Recombinant tissue
plasminogen activator
Rifabutin
Rose bengal
Silver nitrate
Varicella zoster Ig
Spectinomycin
Vasopressin
Terizodone
Yerba buena
Tetracosactide
Zinc
Thiacetazone
Alprazolam
Bromazepam
Morphine
Nalbuphine
Butorphanol
Clonazepam
Codein
Diazepam
Fentanyl
Lorazepam
Methylphenidate
midazolam
Oxycodone
Pethidine (meperidine)
Phenobarbital
Thiopenthal Na
Tramadol
Zolpidem
chemicals (A2)
Ephedrine
Ergotamine
PPA
Tsaang gubat
Yerba buena